INTERNATIONAL PATENT: SANOFI FILES APPLICATION FOR "INTERLEUKIN 2 (IL-2) AND CD123 NK CELL ENGAGER COMBINATION THERAPY"

GENEVA, March 19 -- SANOFI (46 avenue de la Grande Armee75017 Paris) filed a patent application (PCT/US2025/044769) for "INTERLEUKIN 2 (IL-2) AND CD123 NK CELL ENGAGER COMBINATION THERAPY" on Sep 04, 2025. With publication no. WO/2026/055280, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ABBADESSA, Giovanni (c/o Sanofi, Patent Department,450 Water StreetCambridge, Massachusetts 02141), CHIRON, Marielle (c/o Sanofi, Patent Department46 avenue de la Grande Armee75017 Paris), FRAENKEL, Paula (c/o Sanofi, Patent Department,...